Benefits and drawbacks to hormone replacement therapy among nursing home patients

Women's Health Issues

Volumn 8, Issue 1, 1998, Pages 53-59

  Bosworth, Hayden B ^a   Bastian, Lori A ^a,b   Siegler, Ilene C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

AGED; ARTICLE; COST BENEFIT ANALYSIS; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; NURSING HOME; PHARMACIST; POSTMENOPAUSE; QUESTIONNAIRE; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; BREAST NEOPLASMS; CORONARY DISEASE; ENDOMETRIAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LONG-TERM CARE; MEMORY DISORDERS; MIDDLE AGED; NURSING HOMES; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT ADVOCACY; PHARMACISTS; PILOT PROJECTS; RISK FACTORS;

EID: 0031931224     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1049-3867(97)00094-7     Document Type: Article

References (38)

1. 1. Schneider DL, Barrett-Connor EL, Morton DJ. Timing of postmenopausal estrogen for optimal bone mineral density. J Am Med Assoc 1997;277:543-7.
2. 2. Jacobs S, Hillard TC. Hormone replacement therapy in the aged: a state of the art review. Drugs Aging 1996;8:193-213.
3. 3. Handa VL, Landerman R, Hanlon JT, Harris T, Cohen HJ. Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE). J Am Geriatr Soc 1996;44:1-6.
4. 4. Lindsay R, Cosman F, Nieves J. Estrogen: effects and actions in osteoporosis. Osteoporosis Int 1993;3 Suppl 1:S150-2.
5. 5. Lips P. Prevention of hip fractures: drug therapy. Bone 1996;18:159S-63S.
6. 6. Quigley ME, Martin PL, Burnier AM, Brooks P. Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol 1987;156:1516-23.
7. 7. Barrett-Connor E. Risks and benefits of replacement estrogen. In Creger WP, Coggins CH, Hancock EW, editors. Annual review of medicine. Palo Alto (CA): Annual Reviews Inc, 1992:239-51.
8. 8. Felson DT, Zhang Y, Hannon M, Kiel DP, Wilson PW, Anderson J. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993;329:1141-6.
9. 9. Grey AB, Cundy TF, Reid IR. Continuous combined oestrogen/progestogen therapy is well tolerated and increases bone density at the hip and spine in postmenopausal osteoporosis. Clin Endocrinol 1994;40:671-7.
10. 10. Stevenson JC, Kanis JA, Christiansen C. Bone density measurement [letter]. Lancet 1992;339:370-1.
11. 11. Bush TL. The epidemiology of cardiovascular disease in older persons. Aging 1991;3:3-8.
12. 12. Belchetz PE. Hormonal treatment of postmenopausal women. N Engl J Med 1994;330:1062-71.
13. 13. Barrett-Connor E, Bush TL. Estrogen and coronary artery disease in women. J Am Med Assoc 1991;265:1861-7.
14. 14. Ernster VL, Bush TL, Huggins GR, Hulka BS, Kelsey JL, Schottenfeld D. Benefits and risks of menopausal estrogen and/or progestin hormone use. Prev Med 1988;17:201-23.
15. 15. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37.
16. 16. Writing group of the Postmenopausal Estrogen/Progestin Interventions Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors for postmenopausal women. J Am Med Assoc 1995;273:199-208.
17. 17. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary artery disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
18. 18. Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and their risk of cardiovascular disease. N Engl J Med 1996;335:453-61.
19. 19. Henderson BE, Paginini-Hill A, Ross RK. Estrogen replacement therapy and protection from acute myocardial infarction. Am J Obstet Gynecol 1988;159:312-7.
20. 20. Furuhjelm M, Fedor-Freybergh P. The influence of estrogens on the psyche in climacteric and post-menopausal women. In Van Keep PA, Greenblatt RB, Albeaux-Fernet MM, editors. Consensus on menopause research. Baltimore (MD): University Park Press, 1976:84-93.
21. 21. Robinson D, Friedman L, Marcus R, Tinklenberg J, Yesavage J. Estrogen replacement therapy and memory in older women. J Am Geriatr Soc 1994;42:919-22.
22. 22. Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr J 1994;41:361-371.
23. 23. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140:256-61.
24. 24. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997;48:1517-21.
25. 25. Privette M, Cade R, Petersen J, Mars D. Prevention of recurrent urinary tract infections in postmenopausal women. Nephron 1988;50:24-7.
26. 26. Mandel FP, Geola FL, Medlrum DR, et al. Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab 1983;57:133-9.
27. 27. Steinberg KK, Thacker SB, Smith J, et al. A meta-analysis of the effect of estrogen replacement therapy and breast cancer. JAMA 1991;265:1985-90.
28. 28. Dupont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991;151:67-72.
29. 29. Gambrell RD. Hormone replacement therapy and breast cancer risk. Arch Fam Med 1996;5:341-8.
30. 30. Sillero-Arenas M, Delgado-Rodriguez M, Rodigues-Canteras A, et al. Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet Gynecol 1992;79:286-94.
31. 31. Adami H-O, Persson I. Hormone replacement therapy and breast cancer: a remaining controversy? JAMA 1995;274:178-9.
32. 32. Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997;336:1769-75.
33. 33. Cauley J, Cummings S, Black D, Mascioli S, Seeley D. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990;163: 1438-44.
34. 34. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995;85:304-13.
35. 35. Col NF, Eckman MH, Karas RH, et al. Patient-specific decision about hormone replacement therapy in postmenopausal women. JAMA 1997;277:1140-7.
36. 36. U.S. Department of Health and Human Services. Mortality, part B. Vital statistics of the United States: Various years through 1991. Hyattsville (MD): National Center for Health Statistics, 1995.
37. 37. Jacobsen SJ, Goldberg J, Miles TP, et al. Race and sex differences in mortality following fracture of the hip. Am J Pub Health 1992;82:1147-50.
38. 38. Ettinger B, Friedman GD, Bush T, Quesenberry CP, Jr. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 1996;87:6-12.